Abiopharma

NASDAQ symbol attribute type Security_Name was changed. Previous value: Mersana Therapeutics, Inc. - Common Stock. New value: Mersana Therapeutics, Inc. - Common Stock.

Ionis partner GSK announces positive topline results from B-Well 1 and B-Well 2 Phase 3 studies for bepirovirsen, a potential first-in-class medicine for chronic hepatitis B

Innate Pharma - Number of Shares and Voting Rights of Innate Pharma as of December 31, 2025

Addex Spin-Out Neurosterix has started a Phase 1 Clinical Study with M4 PAM - NTX-253 for Schizophrenia

Number of Shares and Voting Rights of Innate Pharma as of December 31, 2025

Praxis Precision Medicines, Inc. Announces Pricing of $575 Million Public Offering

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Director Turtle Cameron 🔴 sold 15.0K shares of Spyre Therapeutics, Inc. (SYRE) at $32.39 Transaction Date: Jan 02, 2026 | Filing ID: 000002

Hurlburt Elizabeth 🔴 sold 10.9K shares of CorMedix Inc. (CRMD) at $12.16 Transaction Date: Jan 02, 2026 | Filing ID: 001938

Zelnick Kaufman Beth 🔴 sold 11.3K shares of CorMedix Inc. (CRMD) at $12.16 Transaction Date: Jan 02, 2026 | Filing ID: 001937

Francis Chris 🟡 adjusted position in 9.4K shares (1 derivative) of Wave Life Sciences Ltd. (WVE) at $16.70 Transaction Date: Jan 02, 2026 | Filing ID: 005195

Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock

📋 Daniel Faga (Officer) plans to sell 15K shares of ANAPTYSBIO, INC (at $44.95 each, total $688K) Filed: Jan 06, 2026 | ID: 000001

SHEA JOHN CHRISTOPHER 🟡 adjusted position in 14.7K shares (6 derivative) of HEALTHCARE SERVICES GROUP INC (HCSG) at $9.88 Transaction Date: Dec 31, 2025 | Filing ID: 000002